NRx Pharma CFO Ira Strassberg and General Counsel Daigneault resign, effective July 18

NRX Pharmaceuticals, Inc.

CFO Ira Strassberg and Chief Corporate Officer/GC Alessandra Daigneault resigned May 19, effective July 18, 2022.
Daigneault leaves to pursue other interests; Deputy General Counsel Michael Kunz expected to assume GC and Secretary role.
Board to conduct search for successor CFO; Strassberg remains until departure.
Departures come about one year after NRx's merger with Big Rock Partners in May 2021.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ira Strassberg

Chief Financial Officer and Treasurer

NRXP · NRX Pharmaceuticals, Inc.

Effective: 2022-07-18
Filed: May 25, 2022, 7:59 PM ET

On May 19, 2022, Mr. Ira Strassberg tendered his resignation as Chief Financial Officer and Treasurer of the Company effective July 18, 2022.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ira Strassberg resigned as Chief Financial Officer and Treasurer at NRX Pharmaceuticals, Inc..

Action: resigned
Role: Chief Financial Officer and Treasurer

Exact text from the filing

On May 19, 2022, Mr. Ira Strassberg tendered his resignation as Chief Financial Officer and Treasurer of the Company effective July 18, 2022.

View on SEC.gov

NRX Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0000950142-22-001710

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.